BEIHAI GOFAR CHUANSHAN BIOLOGICAL CO., LTD.

Beihai Gofar Chuanshan Biological Co., Ltd.

600538

CNE000001DD2

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
4.62 ^CNY	-1.49%		-.--%	-0.43%

29/04	Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
22/04	Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Beihai Gofar Marine Biological Industry Co., Ltd. announced a financing transaction

January 04, 2021

Beihai Gofar Marine Biological Industry Co., Ltd. (SHSE:600538) announced a private placement of common shares on January 4, 2021.

Latest news about Beihai Gofar Chuanshan Biological Co., Ltd.

Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	22/04	CI
Beihai Gofar Chuanshan Biological Gets Patent for Extraction Module	16/04	MT
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25/23/25	CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17/23/17	CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	19/22/19	CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/21/27	CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	26/21/26	CI
Beihai Gofar Chuanshan Biological Co., Ltd. announced that it has received CNY 12.427005 million in funding	28/21/28	CI
Eastern Pioneer Driving School : China stocks edge higher on energy, transport gains	18/21/18	RE
Beihai Gofar Marine Biological Industry Co., Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	26/21/26	CI
Beihai Gofar Marine Biological Industry Co., Ltd. announced a financing transaction	04/21/04	CI
Beihai Gofar Marine Biological Industry Co., Ltd. completed the acquisition of 99.98% stake in Guangzhou Koalson Biotechnology Co.,Ltd. from a group of sellers.	23/20/23	CI
Beihai Gofar Marine Biological Industry Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	29/20/29	CI
Beihai Gofar Marine Biological Industry Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	19/20/19	CI
Beihai Gofar Marine Biological Industry Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	29/20/29	CI
Beihai Gofar Marine Biological Industry Co., Ltd. Predicts Performance Profit in 2019	20/20/20	CI
Beihai Gofar Marine Biological Industry Co., Ltd. agreed to acquire 99.98% stake in Guangzhou Koalson Biotechnology Co.,Ltd. from a group of sellers for approximately CNY 360 million.	04/20/04	CI
Beihai Gofar Chuanshan Biological Co., Ltd. announced that it expects to receive CNY 100 million in funding	03/20/03	CI
Beihai Gofar Marine Biological Industry Co., Ltd. cancelled the acquisition of 30% stake in Beijing Xiangya Medical Technology Co., Ltd. from Beijing Physician Joint Technology Development Center (Limited Partnership), Wang Haolin and Xue Fan.	14/19/14	CI

Chart Beihai Gofar Chuanshan Biological Co., Ltd.

Duration

Period

Chart Beihai Gofar Chuanshan Biological Co., Ltd.

More charts

Beihai Gofar Chuanshan Biological Co Ltd, formerly Beihai Gofar Marine Biological Industry Co Ltd, is a China-based company mainly engaged in the production and sales of pharmaceutical products and pesticide products. The Company is mainly engaged in the Pharmaceutical Distribution segment, the Pharmaceutical Manufacturing segment, the Deoxyribonucleic Acid Identification and Service segment, and the Other segment. The Company is mainly engaged in pharmaceutical manufacturing and pharmaceutical distribution industries, molecular medical imaging centers, tumor radiotherapy centers, and tumor telemedicine technical services, molecular diagnostics and judicial identification technical services. The Company mainly sells its products in the domestic market.

Sector

Pharmaceuticals

Calendar

23/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
BEIHAI GOFAR CHUANSHAN BIOLOGICAL CO., LTD.	-0.43%	33Cr
MCKESSON CORPORATION	+23.03%	7.4TCr
CARDINAL HEALTH, INC.	-1.52%	2.42TCr
SINOPHARM GROUP CO. LTD.	+3.67%	845.99Cr
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+8.55%	834.49Cr
HUADONG MEDICINE CO., LTD	-23.71%	764.38Cr
H. LUNDBECK A/S	+15.20%	532.56Cr
EBOS GROUP LIMITED	-6.90%	391.93Cr
GALENICA AG	+2.68%	411.99Cr
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+5.56%	389.05Cr